Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02912390
Other study ID # 27073a
Secondary ID Cerclage in Twin
Status Terminated
Phase N/A
First received August 2, 2016
Last updated April 11, 2018
Start date January 12, 2017
Est. completion date April 11, 2018

Study information

Verified date April 2018
Source St. Louis University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Through cervical length measurement in uncomplicated twin gestations, women with cervical length ≤ 25 mm will be approached for randomization to cerclage placement or expectant management with activity restriction and treatment of preterm labor


Description:

Pregnant women with twin gestations are screened for short cervix with transvaginal cervical length measurements as part of routine care at St. Mary's Health Center (SMHC) and Saint Louis University's (SLUCare) Physician Group. (Transvaginal cervical length measurement every 2 weeks from 16weeks/0days-23weeks/6days weeks, per hospital practice) Women pregnant with twin gestations at SMHC who meet study criteria will undergo transvaginal length screening between 16 and 24 weeks gestation. Those women with transvaginal cervical length measurements at or below 25 mm will be approached for study participation.

If a patient agrees to participate in the trial, they will be randomized in 1:1 fashion to cerclage vs. expectant management.

Participants found to have a vaginal infection by cultures performed at randomization will be treated with appropriate antibiotics per usual institutional practices

Cerclage arm:

- Macdonald cerclage placed in standard fashion: mersilene suture preferred for standardization

Expectant management arm:

- Patient is placed on activity restrictions: no heavy lifting, frequent reclining, and pelvic rest.

If a participant does not consent to participate in the trial, permission to collect their outcome information in an observational manner will be requested.

The neonatal medical record will be reviewed for outcome data on twins, weights, complications, neonatal intensive care unit (NICU) stay, to 28 day after discharge.


Recruitment information / eligibility

Status Terminated
Enrollment 9
Est. completion date April 11, 2018
Est. primary completion date March 2018
Accepts healthy volunteers No
Gender Female
Age group 14 Years to 45 Years
Eligibility Inclusion Criteria:

- at least 14 years of age, but less than 55 yrs of age

- must be able to read and write English

- must be able to give informed consent.

- Twin pregnancy

Exclusion Criteria:

- Women with a serious physical or mental illness or condition that would substantially interfere with participation in the study

- membrane prolapse beyond the external cervical os,

- major fetal anomaly in either twins will be excluded from randomization.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Cerclage
Macdonald cerclage placed in standard fashion
Other:
Expectant management
placed on activity restrictions: no heavy lifting, frequent reclining, and pelvic rest.

Locations

Country Name City State
United States St. Mary's Health Center Saint Louis Missouri

Sponsors (1)

Lead Sponsor Collaborator
St. Louis University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other cervical and vaginal microbiomes To assess the cervical and vaginal microbiomes as well as presence of vaginal infections to determine potential predictors for spontaneous preterm birth in twin gestations with short cervix 1 year
Primary cervical length = 25 mm. To determine whether cerclage placement in women with twin gestation and cervical length = 25 mm results in pregnancy prolongation. 1 year
Secondary cervical length = 15 mm. To perform a planned subgroup analysis with adequate power to determine whether cerclage placement results in pregnancy prolongation in twins gestations with cervical length = 15 mm. 1 year